iRhythm Technologies Inc (IRTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iRhythm Technologies Inc (IRTC) has a cash flow conversion efficiency ratio of -0.162x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-26.17 Million) by net assets ($161.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See IRTC equity financing ratio to measure how much of total assets are equity-financed.
iRhythm Technologies Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how iRhythm Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of iRhythm Technologies Inc to evaluate the quality of earnings relative to operating cash generation.
iRhythm Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iRhythm Technologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
COPT Defense Properties
NYSE:CDP
|
0.057x |
|
OSI Systems Inc
NASDAQ:OSIS
|
0.074x |
|
National Health Investors Inc
NYSE:NHI
|
0.035x |
|
FIT Hon Teng Limited
F:0FJ
|
0.040x |
|
Zhengzhou Coal Mining Machinery Group Co Ltd
SHG:601717
|
-0.013x |
|
Torex Gold Resources Inc
TO:TXG
|
0.083x |
|
Downer Edi Ltd
AU:DOW
|
0.105x |
|
EQB Inc.
TO:EQB
|
-0.163x |
Annual Cash Flow Conversion Efficiency for iRhythm Technologies Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of iRhythm Technologies Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see IRTC stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $152.75 Million | $80.86 Million | 0.529x | +1319.65% |
| 2024-12-31 | $90.91 Million | $3.39 Million | 0.037x | +115.64% |
| 2023-12-31 | $210.10 Million | $-50.10 Million | -0.238x | -148.51% |
| 2022-12-31 | $239.81 Million | $-23.01 Million | -0.096x | +28.95% |
| 2021-12-31 | $279.51 Million | $-37.75 Million | -0.135x | -235.35% |
| 2020-12-31 | $341.61 Million | $-13.76 Million | -0.040x | +75.05% |
| 2019-12-31 | $135.41 Million | $-21.86 Million | -0.161x | +69.77% |
| 2018-12-31 | $54.42 Million | $-29.07 Million | -0.534x | -184.96% |
| 2017-12-31 | $79.55 Million | $-14.91 Million | -0.187x | -4.19% |
| 2016-12-31 | $92.56 Million | $-16.65 Million | -0.180x | -201.53% |
| 2015-12-31 | $-101.62 Million | $-18.00 Million | 0.177x | +108.24% |
| 2014-12-31 | $7.26 Million | $-15.63 Million | -2.151x | +16.49% |
| 2013-12-31 | $4.60 Million | $-11.85 Million | -2.576x | -- |
About iRhythm Technologies Inc
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more